This Day One Biopharmaceuticals Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Day One Biopharmaceuticals, Inc. +0.09% Pre
Talkspace, Inc. +0.19% Pre
Associated Capital Group, Inc. Class A 0.00% Pre

Day One Biopharmaceuticals, Inc.

DAWN

21.47

21.48

+0.09%

+0.05% Pre

Talkspace, Inc.

TALK

5.18

5.18

+0.19%

0.00% Pre

Associated Capital Group, Inc. Class A

AC

0.00%

0.00% Pre

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keybanc analyst Steve Dechert downgraded the rating for Talkspace Inc (NASDAQ:TALK) from Overweight to Sector Weight. Talkspace shares closed at $5.12 on Monday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Andres Y. Maldonado downgraded Day One Biopharmaceuticals Inc (NASDAQ:DAWN) from Buy to Neutral and cut the price target from $22 to $21.5. Day One Biopharmaceutical shares closed at $21.33 on Monday. See how other analysts view this stock.
  • Scotiabank analyst Konark Gupta downgraded Air Canada (TSX:AC) from Sector Outperform to Sector Perform and cut the price target from C$27 to C$21. See how other analysts view this stock.

Considering buying DAWN stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.